Volume 15, Issue 4 (6-2017)                   IJRM 2017, 15(4): 203-208 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Behrouzi Lak T, Hajshafiha M, Nanbakhsh F, Oshnouei S. N-acetyl cysteine in ovulation induction of PCOS women underwent intrauterine insemination: An RCT. IJRM 2017; 15 (4) :203-208
URL: http://ijrm.ir/article-1-817-en.html
1- Department of Obstetrics and Gynecology, Urmia Reproductive Health Research Center, Urmia, Iran
Abstract:   (5626 Views)
Background: N-acetyl cysteine (NAC) was proposed as an adjuvant to clomiphenecitratefor ovulation induction in patients with polycystic ovary syndrome (PCOS)without clomiphene citrate resistance.
Objective: To evaluate the effect of NAC on pregnancy rate in PCOS patients whowere candidates for intrauterine insemination.
Materials and Methods: In this randomized clinical trial 97 PCOS women aged 18-38 years were enrolled in two groups, randomly. For the case group (n=49), NAC(1.2 gr) + clomiphene citrate (100 mg) + letrozole (5mg) were prescribed dailyfromthe third day of menstruation cycle for five days. The control group (n=48) had thesame drug regimen without NAC. In order to follicular development, GONAL-Fwas injected on days of 7-11 menstrual cycles in all participants. When the folliclesize was 18mm or more, HCG (10000 IU) was injected intramuscular and theintrauterine insemination was performed after 34-36 hr.
Results: There was no significant difference between study groups regarding BMI(p=0.28), FSH level (p=0.66), LH level (p=0.67), mean endometrial thickness(p=0.14), mean number of mature follicles (p=0.20) and the pregnancy occurrence(p=0.09).
Conclusion: NAC is ineffective in inducing or augmenting ovulation in PCOSpatients who were candidates for intrauterine insemination and cannot berecommended as an adjuvant to CC in such patients.
Full-Text [PDF 101 kb]   (1340 Downloads) |   |   Full-Text (HTML)  (6762 Views)  
Type of Study: Original Article |

1. Hendriks ML, König T, Soleman RS, Korsen T, Schats R, Hompes PG, et al. Influence of ovarian manipulation on reproductive endocrinology in polycystic ovarian syndrome and regularly cycling women. Eur J Endocrinol 2013; 169: 503-10. [DOI:10.1530/EJE-13-0334]
2. Shi Y, Wei D, Liang X, Sun Y, Liu J, Cao Y, et al. Live birth after fresh embryo transfer vs elective embryo cryopreservation/frozen embryo transfer in women with polycystic ovary syndrome undergoing IVF (FreFro-PCOS): study protocol for a multicenter, prospective, randomized controlled clinical trial. Trials 2014; 15: 154. [DOI:10.1186/1745-6215-15-154]
3. Maharjan R, Nagar PS, Nampoothiri L. Effect of Aloe barbadensis Mill. formulation on Letrozole induced polycystic ovarian syndrome rat model. J Ayurveda Integr Med 2010; 1: 273-279. [DOI:10.4103/0975-9476.74090]
4. Nam H, Kim CH, Cha MY, Kim JM, Kang BM, Yoo HW. Polycystic ovary syndrome woman with heterozygous androgen receptor gene mutation who gave birth to a child with androgen insensitivity syndrome. Obstet Gynecol Sci 2015; 58: 179-182. [DOI:10.5468/ogs.2015.58.2.179]
5. Bagheri M, Sohrabvand F, Lankarani M, Zandieh Z, Haghollahi F, Shariat M. Comparison of Biomedical Variables in PCOS Patients with Normal Iranian Women. J Family Reprod Health 2015; 9: 5-11.
6. Hendawy SF, Samaha HE, Elkholy MF. Letrozole versus Clomiphene Citrate for Induction of Ovulation in Patients with Polycystic Ovarian Syndrome Undergoing Intrauterine Insemination. Clin Med Insights Reprod Health 2011; 5: 11-16. [DOI:10.4137/CMRH.S6598]
7. Kuang H, Li Y, Wu X, Hou L, Wu T, Liu J, et al. Acupuncture and clomiphene citrate for live birth in polycystic ovary syndrome: study design of a randomized controlled trial. Evid Based Complement Alternat Med 2013; 2013: 527303. [DOI:10.1155/2013/527303]
8. Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 2010; 1:CD003053. [DOI:10.1002/14651858.CD003053.pub4]
9. Farquhar C, Lilford RJ, Marjoribanks J, [DOI:10.1002/14651858.CD001122.pub3]
10. Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 2012; 5:CD003053 [DOI:10.1002/14651858.CD003053.pub5]
11. El-Gharib MN, Mahfouz AE, Farahat MA. Comparison of letrozole versus tamoxifen effects in clomiphen citrate resistant women with polycystic ovarian syndrome. J Reprod Infertil 2015; 16: 30-35.
12. Holzer H, Casper R, Tulandi T. A new era in ovulation induction. Fertil Steril 2006; 85: 277-284. [DOI:10.1016/j.fertnstert.2005.05.078]
13. Nik Hussain NK, Ismail M, Mohd M, Yeu Cp, Rmli R , Wan Mohammad MW, et al.Randomized contralled trial of letrozole versus Chlomiphene citrate for induction of ovulation in polycystic ovarian syndrome (PCOS): A Malaysian experience. Open J Obstet Gynecol 2013; 3: 11-17. [DOI:10.4236/ojog.2013.35A2003]
14. Dorota Magdalena Radomska-Leoeniewska, Piotr Skopi-ski. N-acetylcysteine as an anti-oxidant and anti-inflammatory drug and its some clinical applications. Centr Eur J Immunol 2012; 37: 57-66.
15. Salehpour S, Tohidi M, Akhound MR, Amirzargar N. N Acetyl Cysteine, A novel Remedy for Poly Cystic Ovarian Syndrome. Int J Fertil Steril 2009; 3: 66-73.
16. Kilic-Okman T, Kucuk M. N-acetyl-cysteine treatment for polycystic ovary syndrome. Int J Gynaecol Obstet 2004; 85: 296-297. [DOI:10.1016/j.ijgo.2004.03.002]
17. Roshanayee Y, Comprehensive information official agents of Iran and the world. 3PrdP Ed. Tehran, Roshan book; 2014: 11.
18. Badawy A, State O, Abdelgawad S. N-Acetyl cysteine and clomiphene citrate for induction of ovulation in polycystic ovary syndrome: A cross-over trial. Acta Obstet Gynecol Scand 2007; 86: 218-222. [DOI:10.1080/00016340601090337]
19. Salehpour S, Sene AA, Saharkhiz N, Sohrabi MR, Moghimian F. N-Acetylcysteine as an adjuvant to clomiphene citrate for successful induction of ovulation in infertile patients with polycystic ovary syndrome. J Obstet Gynaecol Res 2012; 38: 1182-1186. [DOI:10.1111/j.1447-0756.2012.01844.x]
20. Rotterdam ESHRE/ASRM-Sponsored PCOS Con-sensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004; 81(1): 19-25 [DOI:10.1016/j.fertnstert.2003.10.004]
21. Thakker D, Raval A, Patel I, Walia R. N-acetylcysteine for polycystic ovary syndrome: a
22. Rizk AY, Bedaiwy MA, Al-Inany HG, N-acetyl-cysteine is a novel adjuvant to clomiphene citrate in clomiphene citrate-resistant patients with polycystic ovary syndrome. Fertil Steril 2005; 83: 367-370. [DOI:10.1016/j.fertnstert.2004.07.960]
23. Nasr A. Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study. Reprod Biomed Online 2010; 20: 403-409. [DOI:10.1016/j.rbmo.2009.12.012]
24. Millea PJ. N-acetylcysteine: multiple clinical applications. Am Fam Physician 2009; 80: 265-269.
25. Oner G, Muderris II. Clinical, endocrine and metabolic effects of metformin vs N-acetyl-cysteine in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2011; 159: 127-131. [DOI:10.1016/j.ejogrb.2011.07.005]
26. Amin AF, Shaaban OM, Bediawy MA. N-acetyl cysteine for treatment of recurrent unexplained pregnancy loss. Reprod Biomed Online 2008; 17: 722-726. [DOI:10.1016/S1472-6483(10)60322-7]
27. Abu Hashim H, Anwar K, El-Fatah RA. N-acetyl cysteine plus clomiphene citrate versus metformin and clomiphene citrate in treatment of clomiphene-resistant polycystic ovary syndrome: a randomized controlled trial. J Womens Health (Larchmt) 2010; 19: 2043-2048. [DOI:10.1089/jwh.2009.1920]
28. Cheraghi E, Mehranjani MS, Shariatzadeh MA, Esfahani MH, Ebrahimi Z.N-Acetylcysteine improves oocyte and embryo quality in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection: an alternative to metformin. Reprod Fertil Dev 2016; 28: 723-731. [DOI:10.1071/RD14182]
29. Maged AM, Elsawah H, Abdelhafez A, Bakry A, Mostafa WA. The adjuvant effect of metformin and N-acetylcysteine to clomiphene citrate in induction of ovulation inpatients with Polycystic Ovary Syndrome. Gynecol Endocrinol 2015; 31: 635-638. [DOI:10.3109/09513590.2015.1037269]
30. Amini L, Tehranian N, Movahedin M, Ramezani Tehrani F, Ziaee S. Antioxidantsand management of polycystic ovary syndrome in Iran: A systematic review ofclinical trials. Iran J Reprod Med 2015; 13: 1-8.

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb